Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients

Eurofins Viracor ExPeCT CAR-T multiplexed quantitative real-time PCR (qPCR) assay provides a powerful diagnostic tool to monitor and optimise CAR-T therapy involving patients with pre-B cell acute

Related Keywords

Dennis Riedl ,Eurofins Viracor ,Contract Research ,European Parliament ,Biopharma Contract Development ,Euronext Paris Stock Exchange ,Chimeric Antigen Receptort Cell ,Eurofins Scientific ,Eurofins ,Miracor ,Aunches ,Ground ,Breaking ,Pest ,Reassessing ,Expansion ,Persistence ,Therapy ,Dancer ,Patients ,